| Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques | Vaccine | 8 hours | save |  |  |  |  |
| Effect of provider recommendation style on the length of adolescent vaccine discussions | Vaccine | 8 hours | save | | | | |
| How should we conduct pandemic vaccination? | Vaccine | 8 hours | save | | | | |
| Vaccine coverage in children born to migrant mothers in Australia: A population-based cohort study | Vaccine | 8 hours | save | | | | |
| Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil – A time series analysis | Vaccine | 8 hours | save | | | | |
| Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine | Vaccine | 8 hours | save | | | | |
| Effect of educational and financial incentive-based interventions on immunization attitudes, beliefs, intentions and receipt among close contacts of pregnant women | Vaccine | 8 hours | save | | | | |
| Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis | Vaccine | 8 hours | save | | | | |
| Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic | Vaccine | 8 hours | save | | | | |
| Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection | Vaccine | 8 hours | save | | | | |
| Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older | Vaccine | 8 hours | save | | | | |
| Assessment of neutralization of Micrurus venoms with a blend of anti-Micrurus tener and anti-ScNtx antibodies | Vaccine | 8 hours | save | | | | |
| Healthcare Workers’ (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis | Vaccine | 8 hours | save | | | | |
| Immunogenicity, duration of protection, effectiveness and safety of rubella containing vaccines: A systematic literature review and meta-analysis | Vaccine | 8 hours | save | | | | |
| Duration of anti-SARS-CoV-2 antibodies much shorter in India | Vaccine | 8 hours | save | | | | |
| A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults | Vaccine | 8 hours | save | | | | |
| Genetic and antigenic characterization of wild type rubella viruses isolated from India | Vaccine | 8 hours | save | | | | |
| Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule | Vaccine | 8 hours | save | | | | |
| The need for inclusion of pregnant women in COVID-19 vaccine trials | Vaccine | 8 hours | save | | | | |
| Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines | Vaccine | 8 hours | save | | | | |
| Editorial Board/Aims and Scope | Vaccine | 8 hours | save | | | | |
| A plasmid encoding the extracellular domain of CD40 ligand and Montanide™ GEL01 as adjuvants enhance the immunogenicity and the protection induced by a DNA vaccine against BoHV-1 | Vaccine | 8 hours | save | | | | |
| Regulatory Harmonization and Streamlining of Clinical Trial Applications globally should lead to faster clinical development and earlier access to life-saving vaccines | Vaccine | 1 day | save | | | | |
| Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 &18): Regulatory toxicology studies in mice, rats and rabbits – An innovative approach | Vaccine | 1 day | save | | | | |
| Vaccination rate and adherence of tick-borne encephalitis vaccination in Germany | Vaccine | 1 day | save | | | | |
| Timing of COVID-19 vaccine approval and endorsement by public figures | Vaccine | 1 day | save | | | | |
| Can a combination of vaccination, probiotic and organic acid treatment in layer hens protect against early life exposure to Salmonella Typhimurium and challenge at sexual maturity? | Vaccine | 1 day | save | | | | |
| Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers | Vaccine | 1 day | save | | | | |
| Constructing an ethical framework for priority allocation of pandemic vaccines | Vaccine | 1 day | save | | | | |
| Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018 | Vaccine | 1 day | save | | | | |
| Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines | Vaccine | 1 day | save | | | | |
| Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore | Vaccine | 1 day | save | | | | |
| Combine two different dengue vaccines could efficiently target dengue-naive subjects. Comment to Macias A, Ruiz-Palacios G, Ramos-Castaneda J. Combine dengue vaccines to optimize effectiveness. Vaccine. 2020 Jun 26;38(31):4801–4804 | Vaccine | 1 day | save | | | | |
| Coping with COVID | Vaccine | 1 day | save | | | | |
| Editorial Board/Aims and Scope | Vaccine | 1 day | save | | | | |
| Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study | Vaccine | 1 day | save | | | | |
| Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013–2020 | Vaccine | 11 days | save | | | | |
| Retraction notice to “Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens” [Vaccine 32(35) (2014) 4428–4435] | Vaccine | 11 days | save | | | | |
| Vaccine sentiments and under-vaccination: Attitudes and behaviour around Measles, Mumps, and Rubella vaccine (MMR) in an Australian cohort | Vaccine | 11 days | save | | | | |
| Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006–2019 | Vaccine | 11 days | save | | | | |
| Vaccination attitudes, beliefs and behaviours among primary health care workers in northern Croatia | Vaccine | 11 days | save | | | | |
| Effectiveness of quadrivalent influenza vaccination in the first year of a funded childhood program in Queensland, Australia, 2018 | Vaccine | 11 days | save | | | | |
| The impact of the changing pneumococcal national immunisation program among older Australians | Vaccine | 11 days | save | | | | |
| Vaccination coverage and adherence to a dengue vaccination program in the state of Paraná, Brazil | Vaccine | 11 days | save | | | | |
| Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naïve and previously immunized adult patients with severe chronic kidney disease | Vaccine | 11 days | save | | | | |
| RTS,S/AS01E malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial | Vaccine | 11 days | save | | | | |
| Human papillomavirus vaccine guideline adherence among Arizona’s Medicaid beneficiaries | Vaccine | 11 days | save | | | | |
| Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging study | Vaccine | 11 days | save | | | | |
| Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis | Vaccine | 11 days | save | | | | |
| A review of hospital-based interventions to improve inpatient influenza vaccination uptake for high-risk adults | Vaccine | 11 days | save | | | | |
| | 
report | next » |
| |
